← Back to Patent Explorer
US4943435A Expired / Lapsed US ⏱️ 0.0 years remaining

Prolonged activity nicotine patch

Assignee: McNeil AB
•
Filing: 1988-10-28
•
Granted: 1990-07-24
•
Expires: 2008-10-28
📄 Original PDF 🌐 Google Patents 🔄 Sync Now

Abstract

Abstract A transdermal patch for delivering nicotine for prolonged periods of 12-24 hours. The patch includes a rate-controlling membrane or monolith to keep the nicotine flux within useful and safe limits. The patch is typically replaced once a day, and can be used for smoking cessation therapy or in other situations where systemic nicotine delivery is indicated.

Inventors

  • 👤 Richard W. Baker
  • 👤 Frank Kochinke
  • 👤 Carl Huang

Bibliographic Details

Application Number —
Jurisdiction US
Data Source google_patents
Last Synchronized 2026-10-23 05:46
CPC Classifications
A; A61; A61K; A61K9/00; A61K9/70; A61K9/7023; A61K9/703; A61K9/7038; A61K9/7046; A61K9/7053; A61K31/00; A61K31/33; A61K31/395; A61K31/435; A61K31/465; A61K9/7069; A61K9/7084

Claims Analysis

Total Claims: 26
Claim 1
Independent Claim 129 words
A transdermal patch, comprising: (a) A nicotine depot layer, having a skin-facing side and a skin-distal side, said depot layer containing a sufficient quantity of nicotine to maintain a useful flux of nicotine from said patch for a total time period of 12 hours or more; (b) an occlusive backing layer in contact with and covering said depot layer on said skin-distal side; and (c) rate-controlling means for controlling diffusion of nicotine from said skin-facing side at a first flux of greater than zero but less than 2 mg/cm 2 in any hour for a first time period of greater than zero but less than 5 hours, then at a second flux between 20 and 800 μg/cm 2 .h for a second time period of 7 hours or more.
Claim 2
Dependent Claim 129 words
A transdermal patch, comprising: (a) A nicotine depot layer, having a skin-facing side and a skin-distal side, said depot layer containing a sufficient quantity of nicotine to maintain a useful flux of nicotine from said patch for a total time period of 12 hours or more; (b) an occlusive backing layer in contact with and covering said depot layer on said skin-distal side; and (c) rate-controlling means for controlling diffusion of nicotine from said skin-facing side at a first flux of greater than zero but less than 2 mg/cm 2 in any hour for a first time period of greater than zero but less than 5 hours, then at a second flux between 20 and 800 μg/cm 2 .h for a second time period of 7 hours or more.
Claim 3
Dependent Claim 22 words
The patch of claim 1, wherein said rate-controlling means comprises a nicotine-permeable polymer membrane contacting said depot layer on said skin-facing surface.
Claim 4
Dependent Claim 19 words
The patch of claim 1, wherein said rate-controlling means comprises a nicotine-permeable polymer monolith integral with said depot layer.
Claim 5
Dependent Claim 35 words
The patch of claim 1, wherein said rate-controlling means comprises a combination of a nicotine-permeable polymer monolith integral with said depot layer and a nicotine-permeable polymer membrane contacting said depot layer on said skin-facing surface.
Claim 6
Dependent Claim 18 words
The patch of claim 1, wherein said depot layer comprises a porous material with said nicotine dispersed therein.
Claim 7
Dependent Claim 12 words
The patch of claim 2, wherein said membrane is made from polyethylene.
Claim 8
Dependent Claim 12 words
The patch of claim 3, wherein said monolith is made from polyurethane.
Claim 9
Dependent Claim 13 words
The patch of claim 4, wherein said membrane is double-sided medical adhesive tape.
Claim 10
Dependent Claim 22 words
The patch of claim 1, wherein said first flux is greater than zero but less than 1 mg/cm 2 in any hour.
Claim 11
Dependent Claim 25 words
The patch of claim 1, wherein said first time period is less than 1 hour, and said second time period is 11 hours or more.
Claim 12
Dependent Claim 92 words
A transdermal patch, comprising: (a) a nicotine depot layer, having a skin-facing side and a skin-distal side, said depot layer containing a sufficient quantity of nicotine to maintain a useful flux of nicotine from said patch for a period of 12 hours or more; (b) an occlusive backing layer in contact with and covering said depot layer on said skin-distal side; and (c) rate-controlling means for controlling diffusion of nicotine from said skin-facing side at a flux between 20 and 800 μg/cm 2 .h for a period of 12 hours or more.
Claim 13
Dependent Claim 92 words
A transdermal patch, comprising: (a) a nicotine depot layer, having a skin-facing side and a skin-distal side, said depot layer containing a sufficient quantity of nicotine to maintain a useful flux of nicotine from said patch for a period of 12 hours or more; (b) an occlusive backing layer in contact with and covering said depot layer on said skin-distal side; and (c) rate-controlling means for controlling diffusion of nicotine from said skin-facing side at a flux between 20 and 800 μg/cm 2 .h for a period of 12 hours or more.
Claim 14
Independent Claim 139 words
A method of administering nicotine to an individual in need of such administration, comprising applying to the skin of said individual a transdermal patch, said patch comprising: (a) a nicotine depot layer, having a skin-facing side and a skin-distal side, said depot layer containing a sufficient quantity of nicotine to maintain a useful flux of nicotine from said patch for a total time period of 12 hours or more; (b) an occlusive backing layer in contact with and covering said depot layer on said skin-distal side; and (c) rate-controlling means for controlling diffusion of nicotine from said skin-facing side at a first flux less 2 mg/cm 2 .h for a first time period less than 5 hours, then at a second flux between 20 and 800 μg/cm 2 .h for a second time period of 7 hours or more.
Claim 15
Independent Claim 139 words
A method of administering nicotine to an individual in need of such administration, comprising applying to the skin of said individual a transdermal patch, said patch comprising: (a) a nicotine depot layer, having a skin-facing side and a skin-distal side, said depot layer containing a sufficient quantity of nicotine to maintain a useful flux of nicotine from said patch for a total time period of 12 hours or more; (b) an occlusive backing layer in contact with and covering said depot layer on said skin-distal side; and (c) rate-controlling means for controlling diffusion of nicotine from said skin-facing side at a first flux less 2 mg/cm 2 .h for a first time period less than 5 hours, then at a second flux between 20 and 800 μg/cm 2 .h for a second time period of 7 hours or more.
Claim 16
Dependent Claim 22 words
The method of claim 12, wherein said rate-controlling means comprises a nicotine-permeable polymer membrane contacting said depot layer on said skin-facing surface.
Claim 17
Dependent Claim 19 words
The method of claim 12, wherein said rate-controlling means comprises a nicotine-permeable polymer monolith integral with said depot layer.
Claim 18
Dependent Claim 35 words
The method of claim 12, wherein said rate-controlling means comprises a combination of a nicotine-permeable polymer monolith integral with said depot layer and a nicotine-permeable polymer membrane contacting said depot layer on said skin-facing surface.
Claim 19
Dependent Claim 18 words
The method of claim 12, wherein said depot layer comprises a porous material with said nicotine dispersed therein.
Claim 20
Dependent Claim 12 words
The method of claim 1, wherein said membrane is made from polyethylene.
Claim 21
Dependent Claim 12 words
The method of claim 14, wherein said monolith is made from polyurethane.
Claim 22
Dependent Claim 13 words
The method of claim 15, wherein said membrane is double-sided medical adhesive tape.
Claim 23
Dependent Claim 16 words
The method of claim 12, wherein said first flux is less than 1 mg/cm 2 .h.
Claim 24
Dependent Claim 25 words
The method of claim 12, wherein said first time period is less than 1 hour, and said second time period is 11 hours or more.
Claim 25
Independent Claim 115 words
A method of administering nicotine to an individual in need of such administration, comprising applying to the skin of said individual a transdermal patch, said patch comprising: (a) a nicotine depot layer, having a skin-facing side and a skin-distal side, said depot layer containing a sufficient quantity of nicotine to maintain a useful flux of nicotine from said patch for a period of 12 hours or more; (b) an occlusive backing layer in contact with and covering said depot layer on said skin-distal side; and (c) rate-controlling means for controlling diffusion of nicotine from said skin-facing side at a flux between 20 and 800 μg/cm 2 .h for a period of 12 hours or more.
Claim 26
Independent Claim 115 words
A method of administering nicotine to an individual in need of such administration, comprising applying to the skin of said individual a transdermal patch, said patch comprising: (a) a nicotine depot layer, having a skin-facing side and a skin-distal side, said depot layer containing a sufficient quantity of nicotine to maintain a useful flux of nicotine from said patch for a period of 12 hours or more; (b) an occlusive backing layer in contact with and covering said depot layer on said skin-distal side; and (c) rate-controlling means for controlling diffusion of nicotine from said skin-facing side at a flux between 20 and 800 μg/cm 2 .h for a period of 12 hours or more.

USPTO Annuity & Maintenance Windows

Annuity Stage Window Opens Payment Deadline Surcharge Period Until Estimated Fee Status
3.5 Years (Year 4) 1993-07-23 1994-01-22 1994-07-24 $2000.00 Window Closed / Lapsed
7.5 Years (Year 8) 1997-07-23 1998-01-22 1998-07-24 $3760.00 Window Closed / Lapsed
11.5 Years (Year 12) 2001-07-23 2002-01-22 2002-07-24 $7700.00 Window Closed / Lapsed

Assigned Categories & Tags

No categories assigned to this patent yet.

Assign Category Tag